Remdesivir modifies interferon response in hospitalized COVID-19 patients.

J Infect

Institute of Clinical Medicine, University of Oslo, Oslo 0318, Norway; Division of Critical Care and Emergencies, Oslo University Hospital, Oslo, Norway. Electronic address:

Published: November 2022

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338165PMC
http://dx.doi.org/10.1016/j.jinf.2022.07.021DOI Listing

Publication Analysis

Top Keywords

remdesivir modifies
4
modifies interferon
4
interferon response
4
response hospitalized
4
hospitalized covid-19
4
covid-19 patients
4
remdesivir
1
interferon
1
response
1
hospitalized
1

Similar Publications

Remdesivir and moxifloxacin hydrochloride are among the most frequently co-administered drugs used for COVID-19 treatment. The current work aims to evaluate green spectrophotometric methodologies for estimating remdesivir and moxifloxacin hydrochloride in different matrices for the first time. The proposed approaches were absorbance subtraction, extended ratio subtraction and amplitude modulation methods.

View Article and Find Full Text PDF

Fungal infection-related conditions and outcomes in severe COVID-19: a nationwide case-control study.

BMC Infect Dis

December 2024

Department of Emergency and Critical Care Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku, Tokyo, 160-8582, Japan.

Background: Fungal infections are significant complications of severe coronavirus disease 2019 (COVID-19). Although various risk factors for poor outcomes in patients with COVID-19 have been identified, clinical and treatment factors associated with fungal infections in patients with severe COVID-19 remain unclear. This study aimed to elucidate clinical factors associated with fungal infections during severe COVID-19 treatment.

View Article and Find Full Text PDF

Background: Multiple sclerosis (MS) is a complex neurodegenerative disease characterized by immune dysregulation, affecting over 2.5 million people worldwide. Interestingly, COVID-19 infection can cause neurodegeneration through demyelination similar to that of MS, and COVID-19 infection can lead to long-term neurological sequelae, post-COVID-19 neurological syndrome.

View Article and Find Full Text PDF

Higher red blood cell distribution width (RDW) levels have gained attention in the prognostication of many chronic metabolic and malignant diseases, as well as coronavirus disease 2019 (COVID-19). We aimed to evaluate whether accounting for RDW might contribute to risk stratification when added to commonly used risk scoring systems in adult COVID-19 patients. We retrospectively analyzed a cohort of 3212 non-critical COVID-19 patients hospitalized in a tertiary-level institution from March 2020 to June 2021.

View Article and Find Full Text PDF

The flap endonuclease-1 mediated maturation of Okazaki fragments is critical for the cellular tolerance to remdesivir.

DNA Repair (Amst)

December 2024

Department of Chemistry, Graduate School of Science, Tokyo Metropolitan University, Minamiosawa 1-1,Hachioji-shi, Tokyo 192-0397, Japan. Electronic address:

Remdesivir is a 1'-cyano-modified adenine nucleotide analog used for the treatment of COVID-19. Recently, the anti-carcinogenic effect of remdesivir has been also identified in human cancers. However, the impact of this drug and the mechanisms underlying the cellular tolerance to remdesivir have not been elucidated.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!